Survival RateRegistriesSEER ProgramSurvival AnalysisIncidencePrognosisAge DistributionNeoplasmsAge FactorsNeoplasm StagingUnited StatesCell SurvivalTime FactorsTreatment OutcomeDisease-Free SurvivalRetrospective StudiesCause of DeathFollow-Up StudiesLife TablesSwedenBreast NeoplasmsFinlandProportional Hazards ModelsWestern AustraliaCombined Modality TherapySurvivalGraft SurvivalSex FactorsSex DistributionColorectal NeoplasmsLung NeoplasmsFranceMultivariate AnalysisRisk FactorsEuropePhilippinesCohort StudiesMortalityKaplan-Meier EstimateSurvivorsProbabilityNetherlandsStomach NeoplasmsAdenocarcinomaLife ExpectancyDeath CertificatesEnglandProstatic NeoplasmsGermanyRisk AssessmentEuropean Continental Ancestry GroupPopulation SurveillanceAntineoplastic Combined Chemotherapy ProtocolsInfant, NewbornRegression AnalysisNeoplasm Recurrence, LocalData Interpretation, StatisticalDatabases, FactualCanadaLiver NeoplasmsSocioeconomic FactorsLymphatic MetastasisActuarial AnalysisChemotherapy, AdjuvantProspective StudiesTumor Markers, BiologicalAntineoplastic AgentsLiver TransplantationApoptosisCisplatinCarcinoma, HepatocellularCarcinoma, Squamous CellNeoplasm MetastasisImmunohistochemistryPostoperative ComplicationsRecurrenceHepatectomyRadiotherapy, AdjuvantDisease ProgressionCarcinoma, Non-Small-Cell LungDoxorubicinVincristineCyclophosphamideReoperationFluorouracilNeoplasm InvasivenessKidney TransplantationCell Line, TumorBrain NeoplasmsPancreatic NeoplasmsRadiotherapy DosageDrug Administration ScheduleEsophageal NeoplasmsRemission InductionGraft RejectionCarcinomaLymph Node ExcisionPredictive Value of TestsSignal TransductionTransplantation, Homologous